Breakthrough
About
Markets
Technology
Products
Investors
CSE: BHSC
OTC: CNVCF
News
BIOHARVEST SCIENCES INC. ANNOUNCES GRANT OF STOCK OPTIONS
BioHarvest Sciences Inc. Announces Partnership with BOLDT and Summit Strategy Group to Develop a Sustainability Framework and ESG Report
BioHarvest Sciences Inc. Announces a Major Breakthrough in the Growth of Cannabis TRICHOMES across Multiple Strains in Liquid Media
BioHarvest Sciences Inc. Signs an Exclusive Agreement with Cukierman & Co. Life Sciences to Explore Pharmaceutical Partnerships for the Use of VINIA® as an Adjuvant Therapy in Type 2 Diabetes Treatments
BIOHARVEST SCIENCES INC. ANNOUNCES CLOSING OF OVERSUBSCRIBED PRIVATE PLACEMENT. COMPANY ISSUES 15,449,829 UNITS AT $0.40 PER UNIT FOR GROSS PROCEEDS OF $6,179,931.60.
BIOHARVEST SCIENCES INC. ANNOUNCES PRIVATE PLACEMENT
BIOHARVEST SCIENCES INC. SHAREHOLDER UPDATE – LIVE EVENT JANUARY 21, 2021 AT 2:00 PM EASTERN STANDARD TIME
BIOHARVEST SCIENCES INC. ADDS DR. DENNIS GOODMAN TO ITS RECENTLY CREATED SCIENTIFIC ADVISORY BOARD
BIOHARVEST SCIENCES INC. ANNOUNCES GRANT OF STOCK OPTIONS
BioHarvest Sciences Inc. Exceeds VINIA Israel Sales Orders Expectations for Q4/2020 and Doubles its 2021 Forecast
BioHarvest Sciences Inc. CEO’s 2020 End of Year Message to Shareholders
BioHarvest Sciences Inc. and Batory Foods announce the first significant B2B VINIA sale in the US
BIOHARVEST SCIENCES INC. Increases VINIA® Israel Sales Order Forecast for 4th Quarter – 2020
Bioharvest Sciences Inc. Delivers a 380% Increase in monthly E-Commerce Revenue with its 2020 Launch of Vinia® B2c On-Line Business in Israel
Bioharvest Sciences Inc.’s Appoints Nathaniel Averill as VP Of Manufacturing, QA & Supply Chain.
Bioharvest Sciences Inc.’s Growth Strategy Progress Update #3 Live Video Conference November 19, 2020 @ 2:00pm EST
Widely Recognized and Experienced Leader in Global Food & Regulatory Industry Joins BioHarvest as Senior Consultant
Next Entries »